Green Cross Health Half Year Report 2017 Presentation
PHARMACY
Highlights
Revenues $166.3m up $8.5m (5.4%)
Operating profit was $13.75m up $1.43m (11.6%)
EBIT Margin has increased from 7.8% to 8.3%
Future Focus
Continued health services development
Working with our supply partners and members
to strengthen our core retail disciplines
Development of digital and personalised
channels including e-commerce
MEDICAL
Future Focus
Growth through acquisition
(full year investment projection $8-$10m)
Includes medical acquisitions in key geographical
areas, co-located with pharmacies where feasible
Improve performancethrough practice leadership
Win contracts for thedelivery of targeted services
Highlights
Patient numbers increased by 5.4% to 220,200
Medical Centre operating earnings increase 36%
Two new Medical Centres joined the Group
COMMUNITY HEALTH
Future Focus
Maximise benefits of a Regularised Workforce
Grow District Nursing and Serious Injury services
Employ IT solutions to deliver improved workforce
efficiency and patient outcomes
Grow profit through operational improvement and new
business
Highlights
Won 50% of the Nelson Marlborough DHB contract
Increases in ACC and Nursing Services revenue
Operating Profit $1.30m up 11.2%
Support worker staff turnover from 29% to 21%
Financial Health
Group Revenue and Profit
H1 2016 to 2017
•6.9% Revenue Growth
•10.8% Underlying Operating Profit Growth
Profitability by Division
H1 YoY
•11.6% Pharmacy Operating Profit Growth
•3.6% Medical Operating Profit Growth
•11.2% Community Health Operating Profit Growth
Cashflow, EPS & Dividend
•Net cash inflow from operating activities was $17.3m versus $6.8m
•Earnings per share increased 11.2% to 6.25 cents on underlying earnings
(excluding 2016 fair value gain)
•Fully imputed interim dividend of 3.5 cents per share to shareholders on
the register as at 5pm on 11 December 2017. The dividend will be paid on
22 December 2017. The dividend reinvestment plan is available to
shareholders.
GXH | GREEN CROSS HEALTH | 2017 Interim Report
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- EBO — EBOS Group Limited: HY Results Presentation2018-02-21
“4 CASH MANAGEMENT LEADERSHIP TRANSITION INFRASTRUCTURE H1 FY18 Strategic Highlights M&A ACTIVITY BRAND DEVELOPMENT STRATEGIC INVESTMENT HPS acquired June 2017 and transition program completed Black Hawk is the fastest growing premium pet food brand in Australia…”
- EBO — EBOS Group Limited: HY Results Media Release2018-02-21
“2 “Our record first half results are in line with our expectations and reflect a consistent positive momentum across both our Healthcare and Animal Care businesses”, said CEO, Patrick Davies. “During the first half, we have fully transitioned HPS into the Group, further e…”
- FPH — Fisher & Paykel Healthcare Corporation Limited: Strong Half Year Result from FPH Record Net Profit NZ$81.3M2017-11-20
“Results in Brief (continued) UNAUDITED Six Months Ended 30 September 2016 NZ$M (except as otherwise stated) Six Months Ended 30 September 2017 NZ$M (except as otherwise stated) % Change CASH FLOWS Net cash flow from operating activities 76.2 82.2 N…”